• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Sciele Pharma to Present at the 19th Annual Piper Jaffray Health Care Conference

Posted on: Wednesday, 21 November 2007, 12:00 CST

Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Darrell Borne, Chief Financial Officer, will make a presentation at the 19th Annual Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Wednesday, November 28, 2007, at 4:30 p.m. Eastern Time.

The audio presentation is being broadcast on the Internet and may be accessed at the Company's website, www.sciele.com.

Sciele Pharma, Inc. Background

Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Heath and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatric products treat allergies, asthma, coughs and colds, and attention deficit and hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Sciele Pharma employs more than 900 people. The Company's success is based upon placing the needs of patients first, improving health and quality of life, and implementing its business platform-an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity and Teamwork.

Source: Business Wire

More News in this Category